Abstract:Objective: To summarize the efficacy, adverse events and prognosis of self-injection of aloprostadil sterille power (prostaglandin E1, PGE1) in 410 patients with erectile dysfunction (ED). Methods: The initial dosage of PGE1 was 10 μg, then was injected into corpus cavernosum penis near the radix penis with injection guns. Rigiscan was used to observe the response of penile erection in the following hours. Optimal injected dosage of each patient with positive reaction was determined. Injected dosage of patients with negative reaction was gradually increased from 20 μg, 30 μg, 40 μg, to 60 μg. As the dosage was established, drugs were taken back to home by the patients for self-injection. Follow-up was made in order to know the information of penile erection, dosage adjustment and adverse events. Results: In 410 ED patients, 139 were considered as psychological, 83 venous, 36 arterial, 78 neurological and the other had combined causes (both psychological and organic). The optimal dosage of PGE1 ranged from 10 to 60 μg in hospital and from 7.5 to 60 μg at home. The induced time of erection varied from 3 to 10 minutes, which was 3 to 25 minutes at home. The time of full erection was 8 to 32 minutes in hospital, however, 8 to 45 minutes of self-injection. 293 patients (71.46%) had pains while injecting. 256 patients (62.44%) were satisfied with the treatment, of which 21(5.1%) patients (psychological ED 14, venous 6, and 1 arterial ED patient) stopped using PGE1 after using five times and healed well with contented sexual life. 171 patients (43.17%) gave up treatment after six months because of penis pain (105 patients), inconvenient manipulation (25 patients), worrying about side effect (37 patients) and other reasons (4 patients). 204 (49.76%) had been using the treatment over one year, 24 patients had been using for over 5 years and 7 patients for over 8 years without finding priapism and corporal fibrosis. There were 20 patients with ecchymosis because of blood vessel injury while injecting. 27 patients were lost to follow up. Conclusion: PGE1 is demonstrated as a safe and effective medicine for ED and can be long-term used. The most frequent side effect is penis pain. Rigiscan is helpful in determining the injection dosage of PGE1.

The role of intracavernous injection and audio-visual sexual stimulation during real-time pharmacopenile Doppler ultrasonog-raphy in diagnosis of vasculogenic erectile dysfunction

[Real-Time Rigiscan Monitoring and Color Doppler Ultrasonography in the Diagnosis of Erectile Dysfunction].

Dynamic Observation of Penile Hemodynamic Change in Patients with Vasculogenic Erectile Dysfunction after Prostaglandin E1 Treatment

Study on diagnostic value of Doppler ultrasonography in vascular erectile dysfunction

Application of Colour Doppler Ultrasonography after Intracavernous Injection in the Diagnosis of Erectile Dysfunction

Application of colour doppler ultrasonography after intracavernous injection in the diagnosis of vasculogenic erectile dysfunction

[Pde-5I Combined with RigiScan-based Audiovisual Sexual Stimulation Test Versus Nocturnal Penile Tumescence Test in Evaluation of Erectile Function].

Efficacy of audiovisual sexual stimulation combined with intracavernous injection of alprostadil in monitoring penile rigidity of patients with erectile dysfunction

Role of duplex ultrasonography,internal pudendal arteriogram and cavernosography in the diagnosis of vascular erectile dysfunction

Evaluation of penile hemodynamics with Doppler ultrasonography combined with oral Sildenafil

Pharmacopenile Doppler Ultrasonograpgy in the Diagnosis of Urethral Trauma Associated with Erectile Dysfunction

Intracaverous injection of aloprostadil sterile power (prostaglandin E1,caverject) for treatment of erectile dysfunction: a 8-Years experience

[The Value of Dynamic Color Duplex Scanning in the Diagnosis of Vascular Erectile Dysfunction].

The diagnostic value of audiovisual sexual stimulation (AVSS) on erectile dysfunction

Diagnostic Accuracy of Different Criteria of Pharmaco-penile Duplex Sonography for Venous Erectile Dysfunction

AB029. The clinical significance of RigiScan plus detection

Pharmaco-induced erections for penile color-duplex ultrasound: oral PDE5 inhibitors or intracavernosal injection?

A novel strategy to induce penile erection during penile doppler ultrasound: oral sildenafil administration plus alprostadil injection

Study on the hemodynamic parameters of the erection penis evoked by Sildenaifl combined with audio-visual sexual stimulation

Why a combined intracavernosal injection with trimix and oral sildenafil is reliable therapy in the ultrasonographic evaluation of erectile dysfunction

Efficient use of penile Doppler ultrasound for investigating men with erectile dysfunction